Delivery Order SPE2DX15D6044-SPE2DX24FCSCH

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $6.4K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,348.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,564,452,073 units of Erythromycin 250 mg tablets in 100-count bottles. The contract is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $25,199.43 firm fixed-price delivery order is for the supply of 4,565,511,300 units of 250mg Erythromycin tablets. The contract has an ultimate completion date of August 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award, valued at $8,222.53, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of 4,568,235,609 units of the pharmaceutical product Erythromycin 250 mg Tablet in 100-count packages. The contract has a period of performance extending through May 14, 2025 and is a firm fixed-price, non-set-aside award....
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued at $1,314.77, is for the delivery of 4,565,477,781 Erythromycin 250 mg tablets in quantities of 100s. The contract is a firm fixed-price Delivery Order with an ultimate completion date of August 19, 2024. Amerisourcebergen is a major pharmaceutical distributor and has been awarded multiple Indefinite Delivery Contracts...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,337.49 firm fixed price delivery order is for the supply of 4,568,189,266 units of Erythromycin 250 mg tablets. The contract has a period of performance through May 9, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $2,598.65 firm fixed-price delivery order is for the supply of 4565333269 - Erythromycin 250 mg tablets, 100 count. The contract has an ultimate completion date of August 5, 2024 and does not utilize a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,677.30 firm fixed-price delivery order is for the supply of 4,564,937,358 units of Erythromycin 3.5GM medication. The contract has an ultimate completion date of July 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, worth $2,599.90, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,891,129 units of Erythromycin 1GM UD 50S, a pharmaceutical product. The contract has an ultimate completion date of July 12, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $2,254.80, is for the delivery of Erythromycin 250 mg tablets to support federal healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This...
This is a Delivery Order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,400.95, is for the supply of 4,567,629,642 units of the drug Erythromycin 250 mg Tablet. The contract is a Firm Fixed Price agreement, with a period of performance through March 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
  • SPE2DX15D6044
    Indefinite Delivery Contract
  • SPE2DX15D6044-SPE2DX24FCSCH
    Delivery Order

This federal contract award, valued at $6,421.63, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,565,289,298 units of Erythromycin 250 mg tablets, a critical pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025 for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract does not have a set-aside designation and is scheduled for completion by July 31, 2024. Amerisourcebergen, as a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leverages its extensive supply chain network to provide essential medications and medical supplies to various defense and civilian agencies, including the military, veterans' healthcare, and other federal healthcare programs.

Generated 10/29/24, 9:05 AM